Acetylsalicylic acid Recruiting Phase 3 Trials for Embolic Stroke / Embolic Stroke of Undetermined Source Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02427126Apixaban for Treatment of Embolic Stroke of Undetermined Source